Specialists & Providers
Diagnostic Biomarkers
Treatments & Interventions
Testosterone
substance
Bromocriptine mesylate
substance
Estrone
substance
Human chorionic gonadotropin
substance
Estrogen receptor agonist-containing product
product
Testosterone propionate
substance
Estradiol benzoate
substance
Estradiol valerate
substance
Estradiol cypionate
substance
Testosterone cypionate
substance
Estradiol hemihydrate
substance
Testosterone enanthate
substance
Polyestradiol phosphate
substance
Ethinylestradiol
substance
Conjugated estrogen
substance
Esterified estrogen
substance
Norethisterone
substance
Norethisterone acetate
substance
Ethynodiol diacetate
substance
Fluoxymesterone
substance
Clinical Trials
Recent Trials
Adaptions and Resiliency to Multi-Stressor OpeRations
52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism
Long Term Effects of Oral Versus Transdermal Estrogen Replacement Therapy in Turner Syndrome
Determining Dose Equivalence Between Oral and Transdermal Estrogen Treatment in Women With Turner Syndrome
A Phase 4 Study to Evaluate Adrenal Function in Hypogonadal Men Treated With JATENZO® for 12 Months
Research Evidence
Peer-reviewed studies linked via MeSH term "Hypogonadism" from the MEDLINE/PubMed database.
Research data from MEDLINE/PubMed
Related Conditions
Quick Facts
- SNOMED CT
- 48130008
- UMLS CUI
- C0020619
- Fully Specified Name
- Hypogonadism (disorder)
- Specialists
- 2
- Diagnostic Biomarkers
- 3
- Known Treatments
- 20
- Clinical Trials
- 52
Related Health Goals
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.